Skip to main content
驱动力 logo

驱动力 — Investor Relations & Filings

Ticker · 920275 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 479 across all filing types
Latest filing 2022-03-29 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920275

About 驱动力

https://www.chinaedrive.com/

Drive Power Bio-tech specializes in the research, development, and manufacturing of functional additives designed for animal nutrition. The company focuses on hematopoietic technology, providing solutions that enhance hemoglobin synthesis, strengthen immune responses, and support intestinal health. Its product portfolio includes specialized nutritional supplements that optimize metabolic processes and improve growth performance. By leveraging biotechnological innovation, the company develops high-efficiency additives aimed at enhancing physiological health and production efficiency in large-scale agricultural environments.

Recent filings

Filing Released Lang Actions
第三届董事会第四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the fourth meeting of the third board of directors of Guangdong Drive Biological Technology Co., Ltd. It includes information about meeting attendance, agenda items, voting results, and references to various reports and announcements already disclosed elsewhere. The content focuses on board meeting decisions, including approval of reports, appointment and resignation of senior management, and other governance matters. It does not contain the full text of any financial report or audit report but rather summarizes board decisions and refers to external disclosures for detailed reports. This fits the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management and related board meeting resolutions.
2022-03-29 Chinese
关于高级管理人员辞职公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of a senior management personnel (board secretary) and details about the impact of this resignation on the company. It includes information about the individual's roles, resignation date, and the effect on the board composition and company operations. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no mention of shareholder votes or capital changes. This fits the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2022-03-29 Chinese
2021年度独立董事述职报告
Management Reports Classification · 95% confidence The document is titled '2021 年度独立董事述职报告' which translates to '2021 Annual Independent Directors' Report'. It details the independent directors' duties, attendance at board meetings, opinions on various company matters, supervision of company governance and information disclosure, and other related activities during the 2021 fiscal year. The content focuses on the independent directors' report on their work and oversight rather than the full annual report or financial statements. It is a specific report by independent directors about their duties and opinions, which aligns with a Management Reports category rather than a full Annual Report or Audit Report. The document length is 2529 characters, which is relatively short but contains substantive content about management oversight and independent directors' activities. Therefore, the best fitting category is Management Reports (MDA).
2022-03-29 Chinese
使用闲置募集资金购买理财产品公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the use of idle raised funds by Guangdong Drive Biological Technology Co., Ltd. It details the amount of funds raised, their usage, storage, and the decision to invest idle funds in financial products. It includes opinions from independent directors, the supervisory board, and the sponsoring institution, and mentions that the proposal requires shareholder approval. The document does not contain financial statements or comprehensive financial data but is an update on capital usage and financing activities related to raised funds. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is 3037 characters, which is consistent with an announcement rather than a full report.
2022-03-29 Chinese
2021年年度报告
Annual Report Classification · 100% confidence The document is titled '年度报告 2021' which translates to 'Annual Report 2021'. It contains detailed sections typical of an annual report such as company overview, financial data and indicators, management discussion and analysis, major events, shareholder information, financing and profit distribution, board and senior management details, industry information, corporate governance, internal controls, and financial accounting reports. The document includes audited financial statements, management certifications, and auditor's unqualified opinion, all consistent with a full annual report. The length of the document (15,000 characters) and the comprehensive content confirm it is the full report, not just an announcement or summary. Therefore, the document is classified as an Annual Report (10-K). FY 2021
2022-03-29 Chinese
华安证券股份有限公司关于广东驱动力生物科技股份有限公司使用闲置募集资金进行现金管理的核查意见
Regulatory Filings
2022-03-29 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.